戻る Agenda
Session 1: Regional and Global Regulatory Priority Updates
Session Chair(s)
Peter Baker
International Relations Specialist, OIP, OGROP
FDA, United States
This session is intended for each National Regulatory Authority (NRA) to provide a summary of the progress made on regional regulatory projects. Each NRA will be allotted approximately 10-20 minutes to provide an update on progress made on various domestic and regional projects (e.g. PAHO, PANDRH) that affect regulators and manufacturers in Latin America. The session will culminate in a Q&A panel discussion to provide additional clarification where necessary.
Learning Objective : At the conclusion of this session, participants should be able to:
Speaker(s)
Speaker
Ariel Arias
Health Canada, Canada
Senior Advisor, Centre for Biologics Evaluation, BGTD
Speaker
Ana Pineda Zavaleta, MSC
FDA, United States
International Regulatory Analyst, LAO, OGPS, OPLIA, OC
Speaker
Daniela Marreco Cerqueira, MS
ANVISA, Brazil
Associate Director, Third Directorate
Speaker
Reina de Acosta
Direccion Nacinal de Medicamentos, El Salvador
Directora Nacional
Speaker
Patricia Aprea, MD
ANMAT, Argentina
Director, Evaluation and Control of Biológicals/Research